Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Saijo

Showing results (41-50 of 456) with videos related to

Pageof 46
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1991
[Preclinical trials from the standpoint of clinical trials]H Okamoto, N Saijo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 8, 2000
[A summary report of response evaluation criteria in solid tumors (RECIST criteria)]H Kusaba, N Saijo
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1986
[Stem cell assay of neoplastic cells]H Takahashi, N Saijo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1992
[An overview of new prognostic factors in lung cancer]A Karato, N Saijo
Seminars in Oncology|April 1, 1997
In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional modelF Kanzawa, N Saijo
Japanese Journal of Cancer Research : Gann|July 1, 1994
Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell linesF Oshita, N Saijo
Gan No Rinsho. Japan Journal of Cancer Clinics|January 1, 1985
[Current perspectives in the management of small cell lung cancer]J Fujita, N Saijo
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1989
[The meaning and prospect of chemosensitivity tests]A Kojima, N Saijo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agentsI Sekine, N Saijo
Clinical Lung Cancer|January 15, 2004
Growth-stimulating pathways in lung cancer: implications for targets of therapyI Sekine, N Saijo
Pageof 46

Showing results (41-50 of 456) with videos related to

Sort By:
Pageof 46
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1991
[Preclinical trials from the standpoint of clinical trials]H Okamoto, N Saijo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 8, 2000
[A summary report of response evaluation criteria in solid tumors (RECIST criteria)]H Kusaba, N Saijo
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 1, 1986
[Stem cell assay of neoplastic cells]H Takahashi, N Saijo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1992
[An overview of new prognostic factors in lung cancer]A Karato, N Saijo
Seminars in Oncology|April 1, 1997
In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional modelF Kanzawa, N Saijo
Japanese Journal of Cancer Research : Gann|July 1, 1994
Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell linesF Oshita, N Saijo
Gan No Rinsho. Japan Journal of Cancer Clinics|January 1, 1985
[Current perspectives in the management of small cell lung cancer]J Fujita, N Saijo
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1989
[The meaning and prospect of chemosensitivity tests]A Kojima, N Saijo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agentsI Sekine, N Saijo
Clinical Lung Cancer|January 15, 2004
Growth-stimulating pathways in lung cancer: implications for targets of therapyI Sekine, N Saijo
Pageof 46